Abstract

Complex formation between the human complement proteins C4b and C2 was investigated by surface plasmon resonance. C4b was immobilised and C2 was used in the fluid phase to measure interaction at different ionic strengths (30–830 mM NaCl) and in the absence and presence of MgCl 2. Maximum binding was observed at 30 mM NaCl, and was negligible above 300 mM NaCl. Binding was not greatly influenced by variation in Mg 2+ in the range of 2.5–15 mM. C4bC2 affinity ( K d) was determined by steady-state analysis to be 7.2×10 −8 M in physiological conditions (10 mM Hepes, 2.5 mM MgCl 2, 0.75 mM CaCl 2 and 140 mM NaCl, pH 7.4). For C4(H 2O)C2 complex formation, a K d of 4.0×10 −8 M was calculated. As far as detected by the applied method, complex formation does not involve conformational changes of one of the binding partners. Consistent with previous reports, C4bC2 binding takes place as a multiple-site binding event in the presence of Mg 2+. C4bC2 complex formation in 10 mM Hepes, 2.5 mM EDTA and 140 mM NaCl (pH 7.4) was also observed and the interaction showed characteristics of a single-site binding event. K d was 1.5×10 −8 M. Complement factor B (FB) was also tested for its binding to immobilised C4b. Weak interaction was observed at FB concentrations in the physiological range (500–1000 nM). K d was 1.2×10 −6 M, indicating possible cross-reactivity between classical and alternative pathways of the activation of the complement system.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.